Fulcrum Therapeutics Inc (NASDAQ:FULC)

4.91
Delayed Data
As of Jul 01
 +0.01 / +0.20%
Today’s Change
3.21
Today|||52-Week Range
33.10
-72.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
Revenue and IncomeNet Revenues0.000.00------
Depreciation And Amortization715.0K1.3M----
 
 
 
 
Operating ExpensesGross Income-715.0K-1.3M----
 
 
 
General Expenses22.3M32.2M----
 
 
 
Research And Development18.5M25.2M----
 
 
 
Total Operating Expenses23.0M33.5M----
 
 
 
 
Non-Operating ExpensesOperating Income-23.0M-33.5M----
 
 
 
Other Expenses28.0K392.0K----
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.0M-32.6M----
 
 
 
Preferred Dividend-2.4M-6.6M----
 
 
 
Net Income-23.0M-32.6M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.3M23.3M----
 
 
 
Shares To Calculate EPS Diluted23.3M23.3M----
 
 
 
 
Earnings Per ShareEPS-$5.09-$4.45----
 
 
 
EPS Diluted-$1.09-$1.68----